triple agonist glp 1 Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care LY3437943, a novel triple glucagon,
Description
Three formative observations in incretin research have shaped this area of drug development, and elevated GLP-1 over GIP as the principal agent
Q., Mao, X
GLP-1 medications may lead to diarrhea in a couple of ways
The jump in share price propelled the stock into positive territory -- it was up nearly 9% year to date as of this writing, and up about 12% over the past 12 months
However, just medication alone isnt going to create lasting change
doi: 10.1111/dom.12084 23 ArslanianSAHannonTZeitlerPChaoLCBoucher-BerryCBarrientos-PrezMet al
